Positive Heparin/PF4 Antibodies and High Mortality Rate: a Retrospective Case-Series Analysis

Ezelsoy M., Saracoglu K. T., Oral K., Saracoglu A., Akpinar B.

BRAZILIAN JOURNAL OF CARDIOVASCULAR SURGERY, cilt.35, sa.6, ss.950-957, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 35 Sayı: 6
  • Basım Tarihi: 2020
  • Doi Numarası: 10.21470/1678-9741-2019-0360
  • Dergi Adı: BRAZILIAN JOURNAL OF CARDIOVASCULAR SURGERY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.950-957
  • Marmara Üniversitesi Adresli: Hayır

Özet

Introduction: Heparin-induced thrombocytopenia (HIT) is a potentially lethal complication of unfractionated or low-molecular weight heparin therapy. We aimed to determine the incidence and mortality rate of patients with positive heparin/platelet factor 4 (PF4) antibodies, which is a rapid detection test of HIT.